Spots Global Cancer Trial Database for A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
Official Title: A Phase 2, Randomized, Open Label Study Of Figitumumab (CP-751,871) Plus Cisplatin (Or Carboplatin) And Etoposide, Versus Cisplatin (Or Carboplatin) And Etoposide Alone, As First Line Treatment In Patients With Extensive Stage Disease Small Cell Lung Cancer
Study ID: NCT00977561
Conditions
Study Description
Brief Summary: This study will summarize the safety of patients receiving figitumumab combined with etoposide and cisplatin (or carboplatin) vs. patients receiving etoposide and cisplatin (or carboplatin) alone as first line treatment for extensive stage disease Small Cell Lung Cancer.
Detailed Description: The study prematurely discontinued on January 26, 2011 due to slow enrollment. It should be noted that safety concerns have not been seen in this study and have not factored into this decision.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Washington, District of Columbia, United States
Pfizer Investigational Site, Washington, District of Columbia, United States
Pfizer Investigational Site, Marrero, Louisiana, United States
Pfizer Investigational Site, Metairie, Louisiana, United States
Pfizer Investigational Site, Creve Coeur, Missouri, United States
Pfizer Investigational Site, St. Louis, Missouri, United States
Pfizer Investigational Site, St. Louis, Missouri, United States
Pfizer Investigational Site, St. Peters, Missouri, United States
Pfizer Investigational Site, Morristown, New Jersey, United States
Pfizer Investigational Site, Hickory, North Carolina, United States
Pfizer Investigational Site, Kernersville, North Carolina, United States
Pfizer Investigational Site, Lenoir, North Carolina, United States
Pfizer Investigational Site, Lexington, North Carolina, United States
Pfizer Investigational Site, Mount Airy, North Carolina, United States
Pfizer Investigational Site, North Wilkesboro, North Carolina, United States
Pfizer Investigational Site, Winston-Salem, North Carolina, United States
Pfizer Investigational Site, Beaverton, Oregon, United States
Pfizer Investigational Site, Gresham, Oregon, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Tualatin, Oregon, United States
Pfizer Investigational Site, West Reading, Pennsylvania, United States
Pfizer Investigational Site, Christiansburg, Virginia, United States
Pfizer Investigational Site, Low Moor, Virginia, United States
Pfizer Investigational Site, Roanoke, Virginia, United States
Pfizer Investigational Site, Salem, Virginia, United States
Pfizer Investigational Site, Wytheville, Virginia, United States
Pfizer Investigational Site, Everett, Washington, United States
Pfizer Investigational Site, Federal Way, Washington, United States
Pfizer Investigational Site, Gig Harbor, Washington, United States
Pfizer Investigational Site, Kennewick, Washington, United States
Pfizer Investigational Site, Lakewood, Washington, United States
Pfizer Investigational Site, Puyallup, Washington, United States
Pfizer Investigational Site, Tacoma, Washington, United States
Pfizer Investigational Site, Oshawa, Ontario, Canada
Pfizer Investigational Site, Sudbury, Ontario, Canada
Pfizer Investigational Site, Levis, Quebec, Canada
Pfizer Investigational Site, Montreal, Quebec, Canada
Pfizer Investigational Site, Budapest, , Hungary
Pfizer Investigational Site, Debrecen, , Hungary
Pfizer Investigational Site, Deszk, , Hungary
Pfizer Investigational Site, Farkasgyepu, , Hungary
Pfizer Investigational Site, Torokbalint, , Hungary
Pfizer Investigational Site, Barcelona, , Spain
Pfizer Investigational Site, Barcelona, , Spain
Pfizer Investigational Site, Las Palmas de Gran Canaria, , Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Malaga, , Spain
Pfizer Investigational Site, Sevilla, , Spain
Pfizer Investigational Site, Sevilla, , Spain
Pfizer Investigational Site, Valencia, , Spain
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
